# A Clinical Study to Investigate the Effects of an Infant Formula Containing Partially Hydrolysed Proteins on Growth, Safety and Tolerance in Healthy Term Infants

> **NCT03062761** · PHASE2 · COMPLETED · sponsor: **Nutricia Research** · enrollment: 380 (actual)

## Conditions studied

- Growth

## Interventions

- **OTHER:** Infant Formula with prebiotics
- **OTHER:** Standard Infant Formula

## Key facts

- **NCT ID:** NCT03062761
- **Lead sponsor:** Nutricia Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-27
- **Primary completion:** 2018-10-26
- **Final completion:** 2018-11-12
- **Target enrollment:** 380 (ACTUAL)
- **Last updated:** 2019-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03062761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03062761, "A Clinical Study to Investigate the Effects of an Infant Formula Containing Partially Hydrolysed Proteins on Growth, Safety and Tolerance in Healthy Term Infants". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03062761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
